CLICK Announces Launch of Cannabis-Based Mouth Spray
Innovative New Product Line Now Available at Select California Dispensaries and Delivery Services
LOS ANGELES, CA, April 14, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – From the land of sunshine and movie stars comes the latest in cannabis innovation for people who want the best cannabis has to offer. CLICK™, a Southern California-based consumer lifestyle sublingual cannabis company, today announced that its inaugural line of sublingual cannabis-based sprays is now available at select dispensaries and delivery services throughout California.
CLICK is for everyone. It’s for people who just want to feel good regardless of the situation or time of day. It’s about living life to the fullest while feeling completely normal. CLICK is for millennials, boomers and everyone in between. From artists and entrepreneurs to gig workers and those trying to capture their dream, CLICK has something for everyone.
Backed by industry insiders, CLICK simplifies the cannabis experience. Simply spray under the tongue and feel effects in as little as six to eight minutes. CLICK’s unique formulation offers control for how much cannabis our customers consume, and the discreet patent-pending bottle design allows CLICK to go wherever they go.
“Right now we have an opportunity to move away from the stigma of administering cannabis by smoking and vaping to a much cleaner, discrete and fun way of experiencing the benefits,” said CLICK Director of Marketing Jared Gray. “As cannabis becomes a larger part of mainstream culture, we hope CLICK will empower consumers to navigate the rapidly growing industry with confidence.”
Each bottle of CLICK is packed with 200mg of cannabinoids which delivers 80 2.5mg sprays in total. The inaugural line features four great-tasting products:
- GO THC – Pep-A-Mint Flavor with Green Tea Extract: Made with the highest grade of THC and paired with uplifting icy-cool peppermint and all-natural green tea extract, GO is perfect for people who want the active and energy-enhanced effects that cannabis can provide.
- RESTORE 1:5 – Lemon Ginger Grass Flavor with Boswellia: Custom-built for those who want to restore their body through the power of cannabis and other natural products, RESTORE strategically combines several ingredients such as THC, CBD, revitalizing all-natural lemongrass extract, calming ginger, and anti-inflammatory Boswellia.
- CHILL 2:1 – TropiCali Flavor with L-Theanine: CHILL uses the synergy between the antioxidant and immunity-boosting properties of all-natural pineapple extract and the probiotic powerhouse effects of mango, as well as L-theanine for heart and brain health and the Vitamin B and C rich properties of passion fruit, to achieve the perfect blend for those looking for a “whole-lotta-relax” in a super small dose.
- DREAM 1:2 – Midnight Mint Flavor with Melatonin: Fall into a deep sleep with the deep-sleep inducing effects of melatonin and aromatic and digestive-aids found in spearmint along with THC and CBD. DREAM is designed to give you the rest you deserve.
Along with industry veterans, professional athletes and influencers; the Company will continue to seek additional investment from proven and strategic investors dedicated to pursuing the vision of a healthier and easier way to consume cannabis.
Founded in California, CLICK™ is an innovative leader in cannabis sublingual offerings. Its products are specifically designed to complement its customers’ lifestyle with their fast-acting features, great taste and ability to fit in the palm of your hand. When sprayed under the tongue, CLICK™ products deliver approximately 2.5mg of cannabis with each pump. Consumers will feel the effects of any of the four formulations GO, RESTORE, CHILL, and DREAM in as little as six to eight minutes. As small as a tube of chapstick, CLICK™ is discreet and designed to join you wherever life leads.
Innovative New Product Line Now Available at Select California Dispensaries and Delivery Services LOS ANGELES, CA, April 14, 2020 (GLOBE NEWSWIRE) — …
What to know about CBD oral sprays
Cannabidiol (CBD) is an increasingly popular ingredient for people seeking alternative remedies for various conditions, including chronic pain. CBD comes in the form of oral sprays, as well as edibles and topical products.
Cannabis plants contain compounds called cannabinoids. The two best-known cannabinoids are tetrahydrocannabinol (THC) and CBD.
THC can lead to psychological effects and the “high” that people frequently associate with cannabis. CBD, however, does not produce the same psychoactive effects. It might, on the other hand, have numerous potential health benefits.
Various forms of CBD exist, including oils, gummies, topicals, and oral sprays. However, it is important to note that availability may vary from state to state, and that it is currently illegal to sell CBD food products or dietary supplements. People can learn more about the regulation of CBD products here.
Keep reading to learn more about the effects and potential benefits of CBD oral sprays. This article also covers how this form of CBD compares with others that are available.
Share on Pinterest CBD oral sprays are faster-acting than CBD edibles, such as gummies.
CBD products are available in many forms, including oral sprays.
Sprays involve a tincture of CBD extract and ethanol alcohol. The alcohol helps extract the cannabinoids. An oral spray dispenses directly into the mouth, either under the tongue or inside the cheek.
Although the research into CBD’s use as a remedy for various conditions is ongoing, studies that support CBD’s purported benefits are currently limited.
The following conditions may benefit from CBD use.
There are anecdotal reports of people who use CBD experiencing anxiety-reducing effects. CBD may also help counteract the anxiety-producing effects linked to high levels of THC.
However, existing studies into the effects of CBD on anxiety involve only small groups of participants. Further research may help clarify the potential link between the two.
Chemotherapy side effects
People undergoing chemotherapy for cancer may experience nausea and vomiting. Doctors usually prescribe antiemetics to counteract these unpleasant side effects.
A 2018 study found that CBD limited a surge of serotonin levels in the interoceptive insular cortex (IIC) of rats that received injections of a nausea-inducing chemical compound.
The IIC region of the human brain is responsible for nausea. Therefore, the findings suggest that it may be possible for scientists to develop a CBD-based antinausea treatment for people receiving chemotherapy treatment.
One 2019 review also suggests that cannabinoids may help prevent other adverse effects associated with chemotherapy, including poor appetite and pain. That said, the evidence in this area is weak.
There is evidence to suggest that cannabinoids may help with pain relief, but few studies exist on CBD specifically.
A 2018 review took into account 48 studies on using cannabinoids and cannabis for the relief of chronic non-cancer-related pain.
The authors suggest that there is moderate evidence pointing to the pain-relieving effects of cannabinoids compared with a placebo. However, people using cannabinoids were also more likely to experience adverse effects than those taking the placebo.
A more recent study analyzed the evidence surrounding the benefits and harms of medical cannabinoids in the treatment of chronic non-cancer-related pain. At 2 weeks, there was “moderate evidence” to support the use of cannabinoids in treating this type of pain.
A 2019 review supports the use of a combined THC and CBD oral spray called nabiximols (Sativex) for multiple sclerosis-related pain. However, the Food and Drug Administration (FDA) have not yet approved this spray for use.
One randomized controlled trial from 2020 suggests a link between topical cannabidiol oil and relief from peripheral neuropathy-related pain. However, the study only looked into topical CBD use, not the use of oral sprays.
Although current evidence does not fully support the use of CBD for relief from chronic pain, new research and clinical trials are on the horizon. For example, the National Center for Complementary and Integrative Health are funding further research on the subject.
Currently, the FDA have only approved a single drug containing CBD. Epidiolex is a treatment option for severe forms of epilepsy called Dravet syndrome and Lennox-Gastaut syndrome.
Clinical trials found that when people with these conditions take Epidiolex with other seizure drugs, they experience fewer seizures than those taking a placebo in addition to seizure medications.
However, there has been little research into the benefits of CBD for milder, more common forms of epilepsy.
Limited evidence suggests that CBD may help people with substance abuse disorder by curbing compulsive behaviors.
A 2018 animal study found that CBD reduced relapse in rats for 5 months.
One study from 2019 found that CBD may help people with heroin use disorder by reducing cravings and anxiety.
Some studies also suggest that CBD may help people with post-traumatic stress disorder by reducing insomnia and nightmares.
Although this preliminary research is encouraging, more studies are necessary to establish conclusive evidence.
For more information and resources on CBD and CBD products, please visit our dedicated hub.
This article will examine the effects and potential benefits of cannabidiol (CBD) oral spray and compare it with other available forms of CBD.